Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer

Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer

US Patent 10751412 · Granted Aug 25, 2020

Estimated economic value: $403,892,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage and administration of anti-C5 antibodies for treatment of atypical hemoly2025
GP130 binding molecules and methods of use2025
Bladed rotor inspection, analysis and repair systems and methods2025
Toll-like receptor antagonist compounds and methods of use2025
Immunogenicity of a CpG-adjuvanted recombinant plague vaccine2025
Immunogenic composition against severe acute respiratory syndrome coronavirus 2 2025
Immunogenic composition against severe acute respiratory syndrome coronavirus 2 2025
IL10RA binding molecules and methods of use2025
IL12 receptor synthetic cytokines and methods of use2025
IL10RB binding molecules and encoding nucleic acids2025
IL2RB binding molecules and methods of use2025
Compositions and methods related to IL27 receptor binding2025